why choose us

First received: June 12, 2025

Clinical Trial: A Study of LY3985863 in Healthy Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Participant- and Investigator-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneou

Brief Summary: The purpose of this study is to evaluate how well LY3985863 is tolerated and what side effects may occur in healthy Chinese participants.The study drug will be administered subcutaneously (SC) (under the skin).Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body.

Read more